Young women ‘not having enjoyable sex’

Sexual satisfaction appears to increase with age, according to a reproductive health poll.

Share Button

NHS ‘poor’ on treating deadly illnesses

The UK system criticised on its track record of caring for heart attacks, strokes and cancer.

Share Button

New gibbon genus discovered in ancient Chinese tomb

Bones of an entirely new but already extinct genus of gibbon have been discovered in China, revealing the magnitude of human-caused extinction of primates, according to a study by UCL and ZSL (Zoological Society of London).

The discovery was made by scientists while studying the contents of a burial chamber in Shaanxi Province, central China and the findings were published today in Science.

The ancient tomb dates from around 2,300 years ago and possibly belonged to Lady Xia — grandmother to China’s first emperor, Qin Shihuang, the leader who ordered the building of the Great Wall of China and the Terracotta Warriors.

The tomb, first excavated in 2004, was found to contain 12 burial pits with animal remains, which included gibbon bones. Sophisticated computer modelling reveals that these ancient bones represent an entirely new genus and species of gibbon, which the team has named Junzi imperialis. Historical records reveal that Junzi probably survived until less than 300 years ago.

Professor Helen Chatterjee (UCL Genetics, Evolution & Environment), an expert on gibbons, worked with colleagues to measure key points on the skull and teeth found in the tomb which were then compared to the dimensions found in the four genera of gibbons living today. Their in-depth analysis revealed that the skull and molars differed by so much that the bones belong to a separate genus to today’s gibbons.

“It’s not surprising that Junzi imperialis is distinct from current gibbon populations as the mammals naturally become isolated from each other in tree tops and can’t cross gaps in the canopy. Even today’s four genera have different numbers of chromosomes,” explained Professor Chatterjee.

Gibbons are the smallest apes and are characterised by their distinctive song and long arms — which they use for moving through the forest canopy by a form of locomotion called brachiation.

They have played an important role in Chinese culture for thousands of years, being present in ancient literature and art. However, despite probably having a venerated status, Junzi became extinct due to past human activities, likely to have included deforestation and hunting.

All of the world’s apes — chimpanzees, gorillas, orang-utans and gibbons — are threatened with extinction today due to human activities, but no ape species were thought to have become extinct as a result of historic hunting or habitat loss until now. The demise of Junzi highlights the vulnerability of gibbons in particular.

“Our discovery and description of Junzi imperialis suggests that we are underestimating the impact of humans on primate diversity. These findings reveal the importance of using historical archives such as the archaeological record to inform our understanding of conservation and stress the need for greater international collaboration to protect surviving populations of gibbons in the wild,” said lead author, Dr Samuel Turvey (ZSL’s Institute of Zoology).

Eastern and Southeast Asia are currently home to some of the world’s most threatened mammals, with 73% of Asian primates being threatened, compared to 60% globally. Two species of gibbon have recently disappeared in China, and all surviving Chinese species are currently classified as Critically Endangered by the IUCN’s Red List of Threatened Species.

The Hainan gibbon (Nomascus hainanus), a species of gibbon found on Hainan Island in southern China, is now probably the world’s rarest mammal, with only 26 surviving individuals.

Story Source:

Materials provided by University College London. Note: Content may be edited for style and length.

Share Button

Inability to recognize faces linked to broader visual recognition problems

Imagine that you’re supposed to meet colleagues for dinner, only you can’t remember what their faces look like. For some, this is a reality, as people with face blindness or developmental prosopagnosia (DP) have severe difficulties recognizing faces, including those of family and friends, despite having no history of brain damage (e.g., brain trauma, head injuries). A Dartmouth study finds that developmental prosopagnosia often occurs as a result of a neurobiological problem in the brain, which affects visual recognition broadly. The findings are published in the Proceedings of the National Academy of Sciences .

“Our results indicate that neural abnormalities in many people with DP are more widespread than previous studies have suggested,” says senior author Bradley Duchaine , a professor of psychological and brain sciences and the principal investigator of the Social Perception Lab at Dartmouth College. Duchaine worked closely with Guo Jiahui, a Dartmouth psychological and brain sciences graduate student and member of his lab, who served as first author of the study.

For the research, the Dartmouth team used functional MRI to measure the brain responses to video clips showing faces, objects, scrambled objects, scenes, and bodies. They then compared these responses in 22 people with developmental prosopagnosia and 25 control participants to determine which regions in the facial processing system may be abnormal and whether any regions that respond preferentially to scenes, bodies, or objects respond abnormally in the developmental prosopagnosics.

This is the first study of DP to use videos of moving faces and is more in line with how one experiences the world, rather than relying on static images of faces. It is also the first fMRI study of its kind to investigate activity in scene and body areas.

The researchers examined 12 face-selective areas throughout the brain (six face-selective areas in each hemisphere). These are different parts of the brain that are interconnected and form the face processing network. The findings showed that DPs had reduced responses to faces but normal responses to objects, scenes, and bodies across all 12 of the face-selective areas.

The study also looked at how DPs responded to visual categories, such as scene areas, body areas and object areas. Known as category-selective areas, the researchers assessed how strongly tuned a cortical area is to a particular category; if the cortex doesn’t develop properly, behavioral deficits ensue. In comparison to the controls, the DPs had pronounced reductions in their responses to scenes and marginal reductions in their responses to bodies. Yet, DPs’ responses to objects in object areas were normal and the same as that of the controls.

“The study participants with developmental prosopagnosia had reduced responses to not only face areas but also to scene areas and body areas. Our findings suggest that most cases of developmental prosopagnosia are not caused by a lack of experience with faces during development but instead, by a broader neurobiological cause that affects all three types of areas,” explained Duchaine. “Our results indicate that the deficits across face areas, scene areas and body areas may be due to a broad region of cortex that did not develop properly. In other words, these areas did not get wired properly during development,” he added.

Past research on visual recognition disorders has focused almost entirely on prosopagnosia; however, the results indicate that many DPs have deficits that extend beyond face areas and it seems likely that abnormalities in scene and body areas will cause difficulties with scene and body perception. Duchaine plans to conduct further research to gain insight into these other visual recognition deficits in order to better understand the types of disorders that impact the visual system.

Duchaine has been conducting research on face perception and face blindness for over 20 years. The findings build on his earlier work, which found abnormalities in some face-selective areas but which did not investigate the entire face network or areas that are selective for other categories such as scenes and bodies.

Story Source:

Materials provided by Dartmouth College. Note: Content may be edited for style and length.

Share Button

Delivering insulin in a pill

Given the choice of taking a pill or injecting oneself with a needle, most of us would opt to regulate a chronic health condition by swallowing a pill. But for millions of people living with type 1 diabetes, a painful needle prick once or twice daily is the only option for delivering the insulin that their bodies cannot produce on their own.

Now, researchers at the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) have developed an oral delivery method that could dramatically transform the way in which diabetics keep their blood sugar levels in check.

Not only does oral delivery of insulin promise to improve the quality of life for up to 40 million people with type 1 diabetes worldwide, it could also mitigate many of the disease’s life-threatening side effects that result from patients failing to give themselves required injections.

The research was published in the Proceedings of the National Academy of Sciences.

Insulin therapy, by injection just under the skin or delivered by an insulin pump, generally keeps the glucose levels of most diabetics in check. “But many people fail to adhere to that regimen due to pain, phobia of needles, and the interference with normal activities,” said senior author Samir Mitragotri, Hiller Professor of Bioengineering and Hansjorg Wyss Professor of Biologically Inspired Engineering at SEAS. “The consequences of the resulting poor glycemic control can lead to serious health complications.”

Finding a way to deliver insulin orally has been elusive; the protein does not fare well when it encounters the stomach’s acidic environment and it is poorly absorbed out of the intestine. The key to the new approach is to carry insulin in an ionic liquid comprised of choline and geranic acid that is then put inside a capsule with an acid-resistant enteric coating. The formulation is biocompatible, easy to manufacture, and can be stored for up to two months at room temperature without degrading, which is longer than some injectable insulin products currently on the market.

“Once ingested, insulin must navigate a challenging obstacle course before it can be effectively absorbed into the bloodstream,” said Mitragotri, who is also a Core Faculty Member at the Wyss Institute for Biologically Inspired Engineering at Harvard. “Our approach is like a Swiss Army knife, where one pill has tools for addressing each of the obstacles that are encountered.”

By encapsulating the insulin-ionic liquid formulation in an enteric coating, the team overcame the first obstacle, resisting breakdown by gastric acids in the gut. This polymer coating dissolves when it reaches a more alkaline environment in the small intestine, where the ionic liquid carrying insulin is released.

“When a protein molecule such as insulin enters the intestine, there are many enzymes whose function is to degrade the proteins into smaller amino acids,” explained first author Amrita Banerjee, who conducted the research while working as a postdoctoral fellow in Mitragotri’s lab, and is now an assistant professor at North Dakota State University. “But the ionic liquid-borne insulin remains stable.”

The choline-geranic acid formulation also was shown to be adept at penetrating two final barriers — the layer of mucus lining the intestine and the tight cell junctions of the intestine wall, through which large-molecule drugs such as insulin cannot easily pass.

Other researchers have tried various means of surmounting these barriers — by re-engineering the insulin molecule, coating it in protective polymers, and introducing additives to inhibit breakdown by enzymes or to enhance absorption. However, no oral insulin delivery product is currently available in the clinic.

“It has been the holy grail of drug delivery to develop ways to give protein and peptide drugs like insulin by mouth, instead of injection,” said Mark Prausnitz, Regents’ Professor and J. Erskine Love, Jr. Chair in Chemical and Biomolecular Engineering at Georgia Institute of Technology. Prausnitz, who was not involved in the research, added: “This study shows remarkable results where insulin given by mouth in combination with an ionic liquid works about as well as a conventional injection. The implications of this work to medicine could be huge, if the findings can be translated into pills that safely and effectively administer insulin and other peptide drugs to humans.”

Orally ingested insulin would more closely mimic the way in which a healthy individual’s pancreas makes and delivers insulin to the liver, where up to 80 percent is extracted and the rest is circulated through the bloodstream. It could also mitigate the adverse effects of taking injections over long period of time.

Banerjee also noted that ionic liquid-borne insulin can be prepared in a one-step process that could be readily scaled up for inexpensive industrial production, making the cost of manufacturing the oral formulation easily manageable.

Mitragotri next plans to conduct more animal tests of the formulation as well as long-term toxicological and bioavailability studies. The researchers are optimistic that if all goes well, gaining approval for eventual clinical trials in humans will be made easier by the fact that the key ingredients in their ionic liquids — choline and geranic acid — are already considered safe. The Food and Drug Administration has established a daily recommended dose of choline, a vitamin-like essential nutrient; and geranic acid, a chemical that naturally occurs in cardamom and lemongrass, is widely used as a food additive.

If further research progresses as hoped, the approach could be used for oral delivery of other proteins.

Harvard’s Office of Technology Development is actively pursuing commercialization opportunities for this technology, and is advancing its development through the Blavatnik Biomedical Accelerator.

Additional authors on the paper include Kelly Isben, Tyler Brown, Renwei Chen and Christian Agatemor.

The research was supported by the National Institutes of Health (grant R01DK097379), the National Science Foundation (DGE-1144085 and DGE-1745303)

Share Button

University student suicide rates revealed

The Office for National Statistics publishes higher education suicide rates for the first time.

Share Button

Health24.com | 7 constipation myths busted

Constipation may not be considered as a serious condition by patients or physicians, and it often isn’t given the attention it deserves. Constipation can be due to a poor diet or the side effects of pain medication; it can, however, sometimes be something more serious.

But before you make any changes to your meal plans or take any drastic steps to obtain a more regular bowel movement, read these seven myths surrounding the causes, dangers and solutions to constipation.

1. Fibre-rich diets can cure constipation

Fibre is often considered a “super food” when it comes to digestion and regular bowel movements, and can be divided into two categories: Soluble fibre and insoluble fibre. Soluble fibre dissolves in water and turns into a gel-like substance. Insoluble fibre does not dissolve in water and helps move food through the digestive tract more quickly. 

According to a study on the effects of dietary fibre on patients with constipation, insoluble fibre was found to have a bulking action that assists with the movement of waste. It also increases the frequency of evacuation. Insoluble fibre can be found in foods like whole-wheat bread, whole grains, fruit skins and seeds.

However, these insoluble fibres may cause gas formation in the intestines and thereby aggravate the condition. This is particularly true for people suffering from chronic constipation.

2. Increasing fluid intake improves bowel movement

Constipation is not only the inability to excrete waste, sometimes it is the painful passing of small, hard stools.

Some people therefore believe that increasing one’s fluid intake will improve the consistency of the stool and thus ease the movement of the bowels.

Researchers say that increasing water intake has little to no effect on stool consistency. However, should a patient be suffering from dehydration and subsequently increase their fluid intake, there would then be a change in stool. 

3. Using laxatives over a prolonged period can cause dependence

While laxatives provide temporary relief, they are not recommended for prolonged use. Laxatives can be divided into two categories: Osmotic laxatives and stimulant laxatives. Osmotic laxatives allow the increase in water secretion to the digestive tract. This improves the consistency of the stool, therefore making it easier to pass. Stimulant laxatives act on the bowel muscles to increase movement and eliminate waste.

According to a study about the myths of constipation, laxatives are not absorbed by the body and the likelihood of addiction is therefore low. Addiction would largely be due to psychological factors. Stimulant laxatives can damage the colon when the recommended dosage is exceeded.  

4. Constipation causes autointoxication and internal putrefaction

The theory of autointoxication comes from the ancient Greeks and Egyptians. This is the belief that constipated patients are at risk of poisoning themselves through the storage of waste in their bodies.

Toxins are believed to be absorbed back into the body if bowel movements are irregular but, thanks to modern science and germ theory, this theory was disproved. 

5. You have to ‘go’ every day

Bowel movements differ for everyone. Some people run a “tight schedule” by using the bathroom every day at the same time, whereas others simply go when the need arises.

The need may be once every three days, but once it surpasses three weeks, you are almost certainly dealing with constipation or even chronic constipation. If the situation carries on, you need to consult your doctor. 

6. Stress stimulates bowel movement

When nervous or stressed, some people may find themselves having to run to the bathroom.

According to Dr Kyle Staller, a gastroenterologist, stress is actually known to cause constipation.

“Many people have that experience where stress causes irregularity of their bowels… Your gastrointestinal tract has many nerves and is a nervous system organ much like the brain. The brain can impact what’s going on in the gastrointestinal tract, and vice versa,” said Dr Staller.

7. Coffee is dehydrating

Dehydration is one of the main causes of chronic constipation. When you are dehydrated, there is not enough water in your colon to excrete waste properly. 

Coffee is a diuretic. Needing to urinate frequently may convince you that you’re losing too much fluid and therefore at risk of dehydration. You might be afraid that drinking coffee will aggravate your constipation or lead to the onset of constipation. But this is not the case. 

Some of us enjoy a hot cup of coffee in the morning to help kick-start our day – and at least 40% of people feel the urge to poo right after. Although researchers have yet to narrow it down, one theory is that the acidity found in coffee triggers your digestive system and activates gastric (stomach) acid.

Image credit: iStock

Share Button

Cancer patients face ‘absurd’ travel insurance costs

Patients are struggling to find affordable travel insurance, long after any key treatment is finished.

Share Button

Health24.com | Is sushi really that healthy?

You’ve seen the Instagram quotes: You had me at sushi. Soy happy together. Keep calm and eat sushi. Corny, sure, but it’s all good because sushi = fish = totally healthy.

That’s true – for the most part. But certain rolls (ahem: the fried and mayo-laden Kamikaze roll) are closer to French fries in nutrition, says registered dietician Jessica Perez.

Not a big deal once in a while – but if you didn’t intend for your seaweed salad to come with a side of saturated fat, disturbing nonetheless.

Read more: 4 things you should never order from the sushi menu

So is sushi healthy?

Yes, Perez says… but again, it really depends on what you order.

Aim for a serving of fatty fish like salmon at least once a week, she says. Fatty fish contains memory-boosting omega-3 fatty acids, so it gets a big thumbs up from most registered dietitians.

But there’s a catch: You should be mindful of your intake of fatty fish like tuna and mackerel, which tend to be higher in mercury. Mercury, of course, is linked to birth defects and can be toxic if consumed at high levels –although some of these fears have been overblown.

Perez recommends only having one or two tuna rolls, and getting the rest of your protein from shrimp, eel or scallops.

The other downside of sushi: One roll can contain up to one cup of rice, according to Perez. Yeah, that’s a lot.

White rice doesn’t have much fibre, and it can really spike your blood sugar (leading to a crash and probably cravings). So you really don’t want to eat more than a cup and a half of rice total all day – and no more than two-thirds a cup at a time, she says.

Ask for fibre-rich brown rice when eating out or swap the white stuff for cauliflower rice or quinoa when you’re making sushi at home.

Of course, if you’re immunosuppressed (undergoing chemo, coping with an autoimmune disease or pregnant) you should steer clear of raw fish altogether. Raw foods carry a slightly higher risk of passing along a bacterial infection, according to Perez. Cooked fish is still on the table, though.

Read more: What 9 nutritionists eat when they’re really damn stressed

Healthy sushi options

The fewer crunchy and creamy add-ons, the better. Swap the spicy mayo for a side of pickled ginger for a similar zing. It’s lower in fat, plus the health benefits of ginger are real.

Here are some great options to order:

The California Roll, which includes clean ingredients like avocado, crab and cucumber.

The Vegetarian Roll, which can include tofu, avocado and a variety of fresh vegetables like carrot and bell pepper.

Sashimi, which is a plain slice of raw fish, or nigiri, which comes with a base of rice (brown is better).

Perez says rolls like these should be avoided (or treated as an occasional indulgence):

  • Anything which is fried on the outside.
  • The Kamikaze Roll, which is loaded with mayo and tempura.
  • The Philadelphia Roll, which contains cream cheese (you’re better off getting your calcium from less processed sources).
  • Tempura or panko rolls, which are just fried filler.

“Get a salmon roll, a veggie roll and California roll, and that’ll be plenty,” Perez says.

The bottom line: There’s room for sushi in your diet – in moderation. Consider limiting rolls that are fried or filled with other high-kilojoule ingredients.

This article was originally published on www.womenshealthmag.com

Image credit: iStock

NEXT ON HEALTH24X

Share Button

MP Carol Monaghan leads campaign for new ME treatment

Patients, carers and MPs say exercise therapy prescribed for chronic fatigue syndrome can be harmful to patients.

Share Button